Megan Hooton

Megan Hooton currently serves as President and Chief Operating Officer at IQVIA Biotech since July 2021, following a substantial tenure at IQVIA where roles included Vice President, Global Head Oncology Project Leadership, and Vice President, Global Project Leadership for Asia Pacific. Megan's expertise encompasses leading full-service clinical projects from phase I to IV, particularly in North Asia. Previous positions include Associate Director at Quintiles and Manager at Bristol-Myers Squibb. Additionally, Megan contributed to the Australian Medical Technology sector as an Advisory Group Member for AusBiotech and AusMedtech. Educational credentials include a Bachelor of Arts in Asian Studies from Monash University and a Critical Care Nursing Certificate from Austin Health, among others.